Closing the gap between evidence and practice in chronic kidney disease

There are major gaps between our growing knowledge of effective treatments for chronic kidney disease (CKD), and the delivery of evidence-based therapies to populations around the world. Although there remains a need for new, effective therapies, current evidence suggests that many patients with CKD are yet to fully realize the benefits of blood pressure –lowering drugs (with and without reducing proteinuria with renin-angiotensin system blockade), wider use of statins to reduce atherosclerotic cardiovascular disease events, and better glycemic control in both type 1 and type 2 diabetes.

Source: Kidney International Supplements - September 20, 2017 Category: Urology & Nephrology Authors: Meg J. Jardine, Bertram Kasiske, Dwomoa Adu, Mona Alrukhaimi, Gloria E. Ashuntantang, Shakti Basnet, Worawon Chailimpamontree, Jonathan C. Craig, Donal J. O'Donoghue, Vlado Perkovic, Neil R. Powe, Charlotte J. Roberts, Yusuke Suzuki, Tetsuhiro Tanaka, Kat Tags: Review Source Type: research